Joint consideration of LDL-C and polygenic risk for incident coronary heart disease in a multi-ethnic cohort of 48,881 individuals

25 April 2024 (16:15 - 17:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Carlos Iribarren

Kaiser Permanente of Northern California, Oakland (United States of America)

5 More presentations in this session

Presentation thumbnail

Klotho protein inhibits extracellular matrix degradation and apoptosis during heart ischemia/reperfusion injury via regulation of the NOS/MMP signalling axis

Doctor A. Olejnik (Wroclaw, PL)

Abstract Slides

Presentation thumbnail

High-dose statins are associated with increased aortic valve calcium load in patients with severe stenosis

Doctor P. Poggio (Milan, IT)

Abstract Slides

Presentation thumbnail

Assessing the impact of long-term high-dose statin treatment on perivascular inflammation and plaque distribution - a comprehensive coronary CTA follow-up study

Doctor B. Matyas (Targu Mures, RO)

Abstract Slides

Presentation thumbnail

Cholesterol paradox for cardiac events: is age the missing link?

Doctor J. Meng (Norwich, GB)

Abstract Slides

Presentation thumbnail

Age-standardized comparison of cardiovascular events and all-cause mortality in people living with HIV and in general population

Doctor A. Camps-Vilaro (Barcelona, ES)

Abstract Slides

Access the full session

Session thumbnail

New factors and mechanisms explaining cardiovascular risk development

The Event

Event poster

ESC Preventive Cardiology 2024

25 April 2024 16:15 CET

You may be interested in

Webinar

Risk assessment and lipid management in primary prevention

Webinar

Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

Practice Tools

Risk Scores in Secondary Cardiovascular Prevention

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources